IQV - Biogen slips as UBS cuts to Neutral on Alzheimer's drug uptake
2024-01-24 08:54:54 ET
More on Biogen, Eisai Co., Ltd., etc.
- Biogen Inc. (BIIB) JPMorgan 42nd Annual Healthcare Conference (Transcript)
- Biogen: LEQEMBI's $10 Billion Potential
- Biogen Inc. (BIIB) Evercore ISI 6th Annual HealthCONx Conference (Transcript)
- Eisai, Biogen file for EU marketing authorization of Alzheimer's drug
- Biogen, Eisai win China approval for Alzheimer's drug